X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

AMERICAN JOURNAL OF PATHOLOGY

期刊標題檢索 AM J PATHOL 最新評論: Pathology is a very classic journal, and the publication process usual... (2024-05-11)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[AMERICAN JOURNAL OF PATHOLOGY]您好,您是該頁面的第 61174 位訪客。

期刊簡介
期刊名稱AMERICAN JOURNAL OF PATHOLOGY AMERICAN JOURNAL OF PATHOLOGY
LetPub Score
7.8
50 ratings
Rate

Reputation
8.8

Influence
6.7

Speed
9.4

期刊簡稱AM J PATHOL
ISSN0002-9440
E-ISSN1525-2191
h-index258
CiteScore
CiteScoreSJRSNIPCiteScore Rank
11.401.6471.135
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pathology and Forensic Medicine
Q19 / 208

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
The American Journal of Pathology, official journal of the American Society for Investigative Pathology, published by Elsevier, Inc., seeks high-quality original research reports, reviews, and commentaries related to the molecular and cellular basis of disease. The editors will consider basic, translational, and clinical investigations that directly address mechanisms of pathogenesis or provide a foundation for future mechanistic inquiries. Examples of such foundational investigations include data mining, identification of biomarkers, molecular pathology, and discovery research. Foundational studies that incorporate deep learning and artificial intelligence are also welcome. High priority is given to studies of human disease and relevant experimental models using molecular, cellular, and organismal approaches.
官方網站http://ajp.amjpathol.org/
在線稿件提交https://www.editorialmanager.com/AJPA
開放訪問No
出版商Elsevier Inc.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1925
每年文章數157每年文章數趨勢
黃金OA百分比74.35%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PATHOLOGYSCIEQ112/88
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0002-9440%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 25%
參考鏈接
相關期刊 【AMERICAN JOURNAL OF PATHOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Annual Review of Pathology-Mechanisms of DiseaseH-index: 105

    CiteScore: 62.60
    ENDOCRINE PATHOLOGYH-index: 42

    CiteScore: 12.30
    ACTA NEUROPATHOLOGICAH-index: 146

    CiteScore: 23.70
    Seminars in ImmunopathologyH-index: 85

    CiteScore: 19.80
    MODERN PATHOLOGYH-index: 139

    CiteScore: 14.30
    BRAIN PATHOLOGYH-index: 124

    CiteScore: 13.20
    JOURNAL OF PATHOLOGYH-index: 168

    CiteScore: 14.10
    ADVANCES IN ANATOMIC PATHOLOGYH-index: 69

    CiteScore: 10.30
    LABORATORY INVESTIGATIONH-index: 140

    CiteScore: 8.30
    AMERICAN JOURNAL OF SURGICAL PATHOLOGYH-index: 193

    CiteScore: 10.30
    學科內最受檢索的期刊 頁面查看次數
    Molecular Medicine Reports314297
    DISEASE MARKERS92609
    PATHOLOGY RESEARCH AND PRACTICE68295
    LABORATORY INVESTIGATION67483
    JOURNAL OF PATHOLOGY65723
    ACTA NEUROPATHOLOGICA44158
    Diagnostic Pathology43859
    PATHOLOGY & ONCOLOGY RESEARCH43748
    MODERN PATHOLOGY41699
    Disease Models & Mechanisms37373
  •  

    AMERICAN JOURNAL OF PATHOLOGY AMERICAN JOURNAL OF PATHOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [AMERICAN JOURNAL OF PATHOLOGY] 的評論撰寫評論
作者: 紫龙一瓜


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-11 15:52:02 評論於
Pathology is a very classic journal, and the publication process usually takes around 5 months. The editors are very nice, and the reviewers are all very professional, providing a lot of valuable feedback. Although the impact factor is a bit low, it does not affect its status in the professional field. I will consider submitting my work to this journal in the future
(0) 讚! | 紫龙一瓜

作者: 昵称是什么啊


領域: 生物学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-03-25 10:54:34 評論於
First of all, the American Journal of Pathology is a classic journal with a good reputation. The review process is comprehensive and strict, and the editors are nice, although the impact factor is not high. The publication process is also relatively smooth. I will consider submitting future manuscripts
(1) 讚! | 昵称是什么啊

作者: 上清曼梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-09 23:55:44 評論於
What progress have we made now?
(0) 讚! | 上清曼梦

作者: 上清曼梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-09 16:18:04 評論於
No need to pay
(0) 讚! | 上清曼梦

作者: 上清曼梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-09 10:49:36 評論於
Receive Good Luck
(0) 讚! | 上清曼梦

作者: 书生芮丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-05 14:21:40 評論於
May 30, 2023 With Editor
(0) 讚! | 书生芮丽

作者: 书生芮丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-05 10:54:23 評論於
Jun 05, 2023 Under Review
(0) 讚! | 书生芮丽

作者: 书生芮丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-26 22:33:56 評論於
How are you doing now?
(0) 讚! | 书生芮丽

作者: 书生芮丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-26 16:44:32 評論於
How are you doing now?
(0) 讚! | 书生芮丽

作者: 书生芮丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-23 20:19:19 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 95.0 
Experience Sharing: May 25, 2023 Submitted to Journal
(0) 讚! | 书生芮丽

作者: 黄土德泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-22 14:24:05 評論於
I also want to ask, do I have to pay to review? Why didn't I see this option?
(0) 讚! | 黄土德泽

作者: 黄土德泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-22 10:43:14 評論於
I also want to know how long it takes for a submission to journal to be processed
(0) 讚! | 黄土德泽

作者: 黄土德泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-20 18:45:29 評論於
Research focus: Cellular mechanism studies; Metabolic diseases; Neutrophil experience sharing: I wanted to ask everyone, is this journal’s review process fast? It is currently in the "Submitted to Journal" status. Do I need to pay $50 for the review? Why didn't I see this in the submission requirements?
(0) 讚! | 黄土德泽

作者: 上清曼梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-02 09:29:26 評論於
Do we need to send all the images used for counting when requesting the organization of the original images?
(0) 讚! | 上清曼梦

作者: Miles Herbert


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-27 11:40:44 評論於
Hello, has there been any updates on the situation later?
(0) 讚! | Miles Herbert

作者: 上清曼梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-15 21:42:09 評論於
How long will it take to get the results after the repair?
(0) 讚! | 上清曼梦

作者: 仙灵芮静


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-04 13:29:16 評論於
Minor repair, hired
(0) 讚! | 仙灵芮静

作者: 上清曼梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-01 15:17:58 評論於
Have you returned? How long has the "under review" status been going on for?
(0) 讚! | 上清曼梦

作者: 上清曼梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-01 12:43:44 評論於
How do you like the article?
(0) 讚! | 上清曼梦

作者: 上清曼梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-15 23:18:15 評論於
How long has it been since your last external audit?
(0) 讚! | 上清曼梦

作者: 上清曼梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-14 20:38:24 評論於
I saw someone saying that there is a $50 fee for submitting a review, have you paid it? Have you received any news from the external review?
(0) 讚! | 上清曼梦

作者: 辰骏大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-01 15:17:47 評論於
Submission success rate: 50.0
Experience sharing: It has been 40 days since submission, and still no news. How much longer do I have to wait?
(0) 讚! | 辰骏大叔

作者: 中原怀瑶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-04 11:11:40 評論於
How long does it usually take for acceptance to publication?
(0) 讚! | 中原怀瑶

作者: 仙灵芮静


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-28 17:44:44 評論於
Research focus: Obesity
Experience Sharing: How many reviewers does this journal usually invite for peer review? After being under review for 2 weeks, the review date has been updated 2 times. Does this mean that the opinions of the two reviewers are not consistent, and the editor has found a third reviewer?
(0) 讚! | 仙灵芮静

作者: 中原怀瑶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-28 09:55:17 評論於
It has been 40 days since the first trial, and there has been no response yet
(0) 讚! | 中原怀瑶

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [AMERICAN JOURNAL OF PATHOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*